Live Breaking News & Updates on ஸ்டிபேல் நிக்கோலஸ் யூரோப் வரையறுக்கப்பட்டவை|Page 11

Stay updated with breaking news from ஸ்டிபேல் நிக்கோலஸ் யூரோப் வரையறுக்கப்பட்டவை. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Investegate |Osirium Technologies Announcements | Osirium Technologies: Proposed Placing and Subscription & Notice of GM


 
THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS NOT FOR PUBLICATION, RELEASE, OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM, THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY JURISDICTION IN WHICH THE SAME WOULD BE UNLAWFUL. THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS FOR INFORMATION PURPOSES ONLY AND SHALL NOT CONSTITUTE AN OFFER TO SELL OR ISSUE OR THE SOLICITATION OF AN OFFER TO BUY, SUBSCRIBE OR ACQUIRE ANY SECURITIES IN THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA (UNLESS AN EXEMPTION UNDER THE RELEVANT SECURITIES LAWS IS AVAILABLE) OR IN ANY OTHER JURISDICTION IN WHICH ANY SUCH OFFER OR SOLICITATION WOULD BE UNLAWFUL. ....

United States , District Of Columbia , United Kingdom , South Africa , City Of , Republic Of South Africa , Stephen Purdham , Rupert Hutton , Fred Walsh Richard , Simon Lee , David Guyatt , Simon Hember , Josh Royston Kieran Breheny , Company The Placing , Company Is Martin Kay , London Stock Exchange , Directors Of The Company , Regulatory Information Service , Financial Conduct Authority , Stifel Nicolaus Europe Limited , Stifel Nicolaus Europe , Company Secretary , European Union Withdrawal , Company The Ordinary , Commission Delegated Directive , Company Or Stifel ,

Investegate |Polarean Imaging PLC Announcements | Polarean Imaging PLC: Exercise of warrants


 
Polarean Imaging plc (AIM: POLX), the medical

imaging technology company, with a proprietary drug

device combination product for the magnetic resonance imaging (MRI) market, announces that that it has received notification from a warrant holder to exercise warrants representing 467,733 ordinary shares of £0.00037 each in the capital of the Company ( Ordinary Shares ). The exercise price of the warrants was 15p per warrant.
 
Application will be made for the 467,733 new Ordinary Shares to be admitted to trading on AIM ( Admission ), which is expected to occur at 8.00 a.m. on or around 22 April 2021. The new Ordinary Shares will rank pari passu with the existing Ordinary Shares. The Company does not hold any Ordinary Shares in treasury. ....

Jonathan Allis , Nick Adams Fred Walsh , Richard Hullihen , Paul Mcmanus Anna Dunphy , Company Ordinary , Stifel Nicolaus Europe Limited , Polarean Imaging Plc , Polarean Inc , Polarean Imaging , Ordinary Shares , Chief Executive , Nicolaus Europe Limited , Sole Corporate Broker , Ben Maddison , Samira Essebiyea , Healthcare Investment Banking , Fred Walsh , Corporate Broking , New Drug Application , Investegate Announcements , Investegate Company Announcements , Polarean Imaging Plc , Egulatory News Service , Egulatory News Service And Regulatory , ஜொனாதன் அல்லிஸ் , நிக் ஆடம்ஸ் ஃப்ரெட் வால்ஷ் ,

Investegate |Polarean Imaging PLC Announcements | Polarean Imaging PLC: Total Voting Rights


+44 (0)20 7710 7600
Nicholas Moore / Ben Maddison / Samira Essebiyea (Healthcare Investment Banking)
Nick Adams / Fred Walsh (Corporate Broking)
Walbrook PR
 
Paul McManus / Anna Dunphy 
 
 
The Company and its wholly owned subsidiary, Polarean, Inc. (together the Group ) are revenue generating, medical drug-device combination companies operating in the high resolution medical imaging market.
 
The Group develops equipment that enables existing MRI systems to achieve an improved level of pulmonary function imaging and specialises in the use of hyperpolarised Xenon gas (
129Xe) as an imaging agent to visualise ventilation and gas exchange regionally in the smallest airways of the lungs, the tissue barrier between the lung and the bloodstream and in the pulmonary vasculature. Xenon gas exhibits solubility and signal properties that ....

Jonathan Allis , Nick Adams Fred Walsh , Richard Hullihen , Paul Mcmanus Anna Dunphy , Stifel Nicolaus Europe Limited , Polarean Imaging Plc , Polarean Inc , Polarean Imaging , Chief Executive Officer , Nicolaus Europe Limited , Sole Corporate Broker , Ben Maddison , Samira Essebiyea , Healthcare Investment Banking , Fred Walsh , Corporate Broking , Hanna Dunphy , Investegate Announcements , Investegate Company Announcements , Regulatory News Service , Regulatory News Service And , ஜொனாதன் அல்லிஸ் , நிக் ஆடம்ஸ் ஃப்ரெட் வால்ஷ் , ரிச்சர்ட் ஹல்லிஹென் , பால் மக்ம்யாநஸ் அண்ணா டன்ஃபி , ஸ்டிபேல் நிக்கோலஸ் யூரோப் வரையறுக்கப்பட்டவை ,